PARASAL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Parasal, and when can generic versions of Parasal launch?
Parasal is a drug marketed by Panray and is included in one NDA.
The generic ingredient in PARASAL is aminosalicylate sodium. There are three drug master file entries for this compound. Additional details are available on the aminosalicylate sodium profile page.
Summary for PARASAL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 151 |
Patent Applications: | 1,941 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PARASAL at DailyMed |
US Patents and Regulatory Information for PARASAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Panray | PARASAL | aminosalicylic acid | TABLET;ORAL | 006811-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Panray | PARASAL SODIUM | aminosalicylate sodium | TABLET;ORAL | 006811-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Panray | PARASAL | aminosalicylic acid | TABLET;ORAL | 006811-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |